PH vs PRLD · P/E 28, rev $19.85B vs rev $6.5M
Parker-Hannifin Corporation (PH) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
PH currently screens at market cap $91.89B and trailing P/E 27.7. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the PH and PRLD stock pages for the full models.
Not investment advice.